Here you can find general information about the company intended for journalists and other stakeholders
Established in 2005, Arterium Corporation is one of the leading Ukrainian pharmaceutical companies. It integrates two Ukrainian companies Kievmedpreparat and Galychpharm, which have over 150 years of pharmaceutical manufacturing experience.
National flagship producer
of antibacterial medicines
With a history dating back to 1847, Kievmedpreparat manufactures generic and original medicines in such forms as injections in vials, tablets, capsules, ointments, gels, and suspensions. In 2006, the company started making veterinary medicinal products too.
of herbal medicinal products
Galychpharm has been producing medicinal products since 1911. The company offers diverse product range of generic and original medicinal products available in the following pharmaceutical forms: injections in ampoules, tablets, infusions, extracts, syrups, and drops.
Quality management systems of both enterprises meet the international environmental management standard DSTU ISO 14001:2006. Also, their manufacturing facilities are certified for compliance with the Good Manufacturing Practice standards.
LLC “ARTERIUM LTD”
Provider of complex and professional solutions in the field of pharmaceutical regulatory issues
LLC “ARTERIUM LTD” is a company founded in 2008. Since 2016 it provides a wide range of services in the sphere of cooperation with regulatory bodies. The list of services includes registration and maintenance of registration certificates, pharmacovigilance and other consulting services. The team of highly qualified specialists has the experience of successfully operating in 16 countries for 6 product categories: active pharmaceutical ingredients, medicines for human use, veterinary medicines, herbal medicines, medical products, dietary supplements.
Quality management systems of ARTERIUM LTD meet the requirements of the international quality management standard ISO 9001.
With representative offices in Azerbaijan, Belarus, Kazakhstan, Russia, and Uzbekistan, Arterium Corporation is committed to becoming the regional market leader in all these countries. The total salesforce of our representative offices exceeds 200 employees. We export our products to 11 CIS countries and Vietnam, exports accounting for almost 25% of the сompany’s income in recent years.
Product portfolio of Arterium Corporation includes both generic and original medicinal products in 11 of 14 pharmacotherapeutic groups.
140 medicinal products in our portfolio
NERVOUS SYSTEM MEDICATIONS
Among our best-known original drugs are Thiotriazolin, L-lysine aescinate®, Tiocetam, and Urolesan, which hold a special place in Arterium Corporation’s product portfolio.
If you have any questions, suggestions or complaints, please submit them below
If you have information about any adverse effects or other drug-related problems, please fill in the form
Prescription and over-the-counter medicines